Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of HEATR2 mRNA | increases expression | 18687144
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of HEATR2 mRNA | decreases expression | 18042831
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in decreased expression of HEATR2 mRNA | affects cotreatment|decreases expression | 17183730
|
C041786 |
palm oil |
palm oil results in decreased expression of HEATR2 mRNA | decreases expression | 18042831
|
D014302 |
Trinitrobenzenesulfonic Acid |
Trinitrobenzenesulfonic Acid results in decreased expression of HEATR2 mRNA | decreases expression | 17982090
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in decreased expression of HEATR2 mRNA | affects cotreatment|decreases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.95 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.25 | 19490988 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.75 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.83 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
4.31 | 15238619 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 17157402 18558336 18940202 17507914 18177632 15238991 19232924 18316065 16609825 20603192 18775368 18985861 18396377 19460635 17688650 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.21 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.59 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.25 | 20435547 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.80 | 20734317 |
MESH:D003092 |
Colitis |
|
Trinitrobenzenesulfonic Acid |
4.96 | 16474422 17936198 16804969 16867261 18200517 17991707 16782535 18023891 11698051 |
MESH:D003093 |
Colitis, Ulcerative |
|
Trinitrobenzenesulfonic Acid |
3.53 | 17276891 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 16575769 8888407 17688650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
2.24 | 19641884 1733752 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.67 | 18367378 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.40 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.57 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.44 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.07 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.87 | 6254150 6426943 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.71 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.53 | 3659116 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
9.00 | 18296743 17967931 19004024 19551842 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
9.00 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.41 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.51 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
10.57 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Trinitrobenzenesulfonic Acid |
10.57 | 17994277 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.33 | 17688650 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.92 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.97 | 21332399 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
5.04 | 16612254 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
2.57 | 20412841 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Trinitrobenzenesulfonic Acid |
3.68 | 18200517 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.30 | 18457598 11836018 |
MESH:D007410 |
Intestinal Diseases |
|
Trinitrobenzenesulfonic Acid |
5.02 | 17994277 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.19 | 16294345 17596541 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
3.03 | 18296743 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.78 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.44 | 17365036 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.28 | 18303189 16966607 16166281 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.41 | 18803445 18765137 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.35 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.31 | 17596541 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.32 | 16359493 8888407 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.34 | 17217161 18674790 21332399 19632207 20518802 11836018 18457598 16723640 20132043 |
MESH:D010195 |
Pancreatitis |
|
Trinitrobenzenesulfonic Acid |
4.55 | 17698068 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
5.31 | 10923243 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.29 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.06 | 12752131 11422049 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.13 | 15814490 17365031 17975199 17322281 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.53 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.10 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.94 | 11044598 11738929 3137016 16876388 14763951 15475178 1511512 17978042 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.02 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.06 | 12833885 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.75 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.98 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.06 | 8888407 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
4.02 | 16723640 |